Sarvilina, I. V., Dydykina, I. S., & Lila, A. M. (2022). Current possibilities of pharmacological correction of neuroimmune joint damage in patients with knee osteoarthritis in long COVID conditions. IMA-PRESS LLC.
Chicago Style (17th ed.) CitationSarvilina, I. V., I. S. Dydykina, and A. M. Lila. Current Possibilities of Pharmacological Correction of Neuroimmune Joint Damage in Patients with Knee Osteoarthritis in Long COVID Conditions. IMA-PRESS LLC, 2022.
MLA (9th ed.) CitationSarvilina, I. V., et al. Current Possibilities of Pharmacological Correction of Neuroimmune Joint Damage in Patients with Knee Osteoarthritis in Long COVID Conditions. IMA-PRESS LLC, 2022.
Warning: These citations may not always be 100% accurate.